Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bhaskar Anand currently holds 30,000 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bhaskar Anand has been a net seller of RETA stock. They have purchased $0 and sold $554.3K worth of shares.
Bhaskar Anand's most recent insider trade was on Jan 8, 2026, when they sold 30,000 shares at $0.00 per share.
Bhaskar Anand serves as Executive at REATA PHARMACEUTICALS INC (RETA). They have executed 17 insider transactions totaling $554.3K over their tenure at the company.
Bhaskar Anand holds the position of Executive at REATA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Bhaskar Anand has shown a selling trading pattern, with $0 in total purchases and $554.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bhaskar Anand was on Sep 11, 2024, when they purchased $500.0K worth of SMMT shares. This transaction involved 22,026 shares at $22.70 per share.
Bhaskar Anand currently owns 30,000 shares of REATA PHARMACEUTICALS INC (RETA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bhaskar Anand's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bhaskar Anand has 17 Form 4 filings on record as an insider at REATA PHARMACEUTICALS INC.
Set alerts for Bhaskar Anand and 40,000+ other insiders.